130406-33-6

Basic information

• Product Name: (R)-α-(azidomethyl)-2-phenylethanamine
• Synonyms: (R)-α-(azidomethyl)-2-phenylethanamine
• CAS NO: 130406-33-6
• Molecular Weight: 176.221
• Mol File: 130406-33-6.mol
• Article Data: 5

Chemical Properties

• CAS DataBase Reference: (R)-α-(azidomethyl)-2-phenylethanamine(CAS DataBase Reference)
• NIST Chemistry Reference: (R)-α-(azidomethyl)-2-phenylethanamine(130406-33-6)
• EPA Substance Registry System: (R)-α-(azidomethyl)-2-phenylethanamine(130406-33-6)

Safety Data

• Hazardous Substances Data: 130406-33-6(Hazardous Substances Data)

Upstream product

• 126301-19-7 (2R)-2-[(tert-butoxycarbonyl)amino]-3-phenylpropyl methanesulfonate 
• 106454-69-7 N-tert-butoxycarbonyl-D-Phenylalaninol 
• 5267-64-1 (R)-2-amino-3-phenylpropanol 
• 190839-76-0 (2R)-tert-butyl-(2-azidomethyl-1-benzylethyl) carbamate 
• 130406-30-3 9H-fluoren-9-ylmethyl (R)-<1-(hydroxymethyl)-2-phenylethyl>carbamate 

Downstream Products

• 85612-59-5 (R)-3-phenylpropane-1,2-diamine 
• 881207-16-5 (R)-N₂-(3-azido-1-phenylpropan-2-yl)-N₄-methyl-N₄-(2-phenylpyrimidin-4-yl)-pyrimidine-2,4-diamine 
• 130406-52-9 [(S)-1-((R)-1-Aminomethyl-2-phenyl-ethylcarbamoyl)-2-(1H-indol-3-yl)-1-methyl-ethyl]-carbamic acid adamantan-2-yl ester 
• 130406-52-9 [(R)-1-((R)-1-Aminomethyl-2-phenyl-ethylcarbamoyl)-2-(1H-indol-3-yl)-1-methyl-ethyl]-carbamic acid adamantan-2-yl ester 
• 130406-60-9 *,S^*)>-4-<<2-<<3-(1H-indol-3-yl)-2-methyl-1-oxo-2-<<(tricyclo<3.3.1.1^3,7>dec-2-yloxy)carbonyl>amino>propyl>amino>-3-phenylpropyl>amino>-4-oxobutanoic acid 
• 130406-58-5 *,R^*)>-4-<<2-<<3-(1H-indol-3-yl)-2-methyl-1-oxo-2-<<(tricyclo<3.3.1.1^3,7>dec-2-yloxy)carbonyl>amino>propyl>amino>-3-phenylpropyl>amino>-4-oxobutanoic acid 
• 890139-90-9 2-((R)-1-Azidomethyl-2-phenyl-ethylcarbamoyl)-5-{(R)-3-[3-((S)-2-phenyl-1-prop-2-ynylcarbamoyl-ethyl)-ureido]-4-triisopropylsilanyloxy-butyl}-furan-3,4-dicarboxylic acid dimethyl ester 
• 890139-86-3 2-((R)-1-Azidomethyl-2-phenyl-ethylcarbamoyl)-5-{(R)-3-[3-((R)-2-phenyl-1-prop-2-ynylcarbamoyl-ethyl)-ureido]-4-triisopropylsilanyloxy-butyl}-furan-3,4-dicarboxylic acid dimethyl ester 
• 890139-84-1 2-((R)-1-Azidomethyl-2-phenyl-ethylcarbamoyl)-5-{(S)-3-[3-((R)-1-benzyl-prop-2-ynyl)-ureido]-4-triisopropylsilanyloxy-butyl}-furan-3,4-dicarboxylic acid dimethyl ester 
• 890139-80-7 2-((R)-1-Azidomethyl-2-phenyl-ethylcarbamoyl)-5-{(S)-3-[3-((S)-1-benzyl-prop-2-ynyl)-ureido]-4-triisopropylsilanyloxy-butyl}-furan-3,4-dicarboxylic acid dimethyl ester 
• 890140-39-3 2-((R)-1-Azidomethyl-2-phenyl-ethylcarbamoyl)-5-{(R)-3-[3-((R)-1-benzyl-prop-2-ynyl)-ureido]-4-triisopropylsilanyloxy-butyl}-furan-3,4-dicarboxylic acid dimethyl ester 
• 890140-42-8 2-((R)-1-Azidomethyl-2-phenyl-ethylcarbamoyl)-5-{(R)-3-[3-((S)-1-benzyl-prop-2-ynyl)-ureido]-4-triisopropylsilanyloxy-butyl}-furan-3,4-dicarboxylic acid dimethyl ester 
• 890139-71-6 dimethyl 2-(((R)-1-azido-3-phenylpropan-2-yl)carbamoyl)-5-((S)-3-(3-methyl-3-(prop-2-ynyl)ureido)-4-(triisopropylsilyloxy)butyl)furan-3,4-dicarboxylate 
• 890139-51-2 2-allyl 3,4-dimethyl 5-((S)-3-(3-((R)-1-azido-3-phenylpropan-2-yl)ureido)-4-(triisopropylsilyloxy)butyl)furan-2,3,4-tricarboxylate 

Relevant articles and documents

6-O-SUBSTITUTED KETOLIDES HAVING ANTIBACTERIAL ACTIVITY

PROBLEM TO BE SOLVED: To provide 6-O-substituted ketolides with antibacterial activity, having acid stability and enhanced activity toward gram negative bacteria and macrolide resistant gram positive bacteria. SOLUTION: This invention provides 6-O-substituted erythromycin ketolide derivatives such as formula (II) and compositions comprising the compounds. [Y and Z together form a group X; X is ketone, hydroxyimino or the like; or, one of Y and Z is H and the other is hydrogen, hydroxy or the like; Ra is H, hydroxy; Rc is H or a hydroxy protective group; R is a substituted methyl group]. COPYRIGHT: (C)2015,JPOandINPIT

Tricyclic erythromycin derivatives

Compounds, or pharmaceutically acceptable salts and esters thereof, of the formula: wherein A, B, D and E, R1, R2, and Z are specifically defined, having antibacterial activity, pharmaceutical compositions containing said compounds, treatment of bacterial infections with such compositions, and processes for the preparation of the compounds.

Rationally Designed "Dipeptoid" Analogues of CCK. α-Methyltryptophan Derivatives as Highly Selective and Orally Active Gastrin and CCK-B Antagonists with Potent Anxiolytic Properties

This paper describes the synthesis and structure-activity relationships (SAR) leading to the first rational design of "dipeptoid" analogues of the neuropeptide cholecystokinin (CCK).Compounds *,S*)>-4-2-3-(1H-indol-3-yl)-2-m